NCT04121780View on ClinicalTrials.gov

Growth Hormone Replacement Therapy for Retried Professional Football Players

PHASE2RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 8, 2019

Primary Completion Date

March 31, 2025

Study Completion Date

September 30, 2026

Conditions
TBI (Traumatic Brain Injury)Concussion, BrainSport InjuryAnterior Pituitary Hyposecretion SyndromeHypopituitarismGrowth Hormone Deficiency
Interventions
BIOLOGICAL

Growth Hormone

"Daily self-injections by subjects:~1-year double-blind phase; 6-month open-label extension for those who received placebo during the double-blind phase"

OTHER

Placebo

"Daily self-injections by subjects:~1-year double-blind phase"

Trial Locations (1)

48126

RECRUITING

Center for Neurolgoical Studies (CNS), Dearborn

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Center for Neurological Studies

OTHER